Atrás
Rango del Día
$62.73
$65.13
Rango de 52 Semanas
$10.81
$94.57
Volumen
201,935
Promedio 50D / 200D
$75.51
/
$51.38
Cierre Anterior
$60.92
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.7 | 0.4 |
| P/B | 117.6 | 2.9 |
| ROE % | -197.9 | 3.7 |
| Net Margin % | -10773.5 | 3.9 |
| Rev Growth 5Y % | -34.6 | 10.0 |
| D/E | 13.4 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.75
$1.75 – $1.75
|
190 M | 1 |
| FY2029 |
$0.22
$0.22 – $0.22
|
130 M | 1 |
| FY2028 |
-$0.95
-$0.95 – -$0.95
|
98 M | 1 |
Puntos Clave
Revenue declined -34.64% annually over 5 years
Earnings declined -108.30% over the past year
Debt/Equity of 13.39 — high leverage
Negative free cash flow of -129.83M
PEG of 0.08 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 584.64%
Crecimiento
Revenue Growth (5Y)
-34.64%
Revenue (1Y)550.00%
Earnings (1Y)-108.30%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-197.85%
ROIC-88.06%
Net Margin-10773.46%
Op. Margin-10386.54%
Seguridad
Debt / Equity
13.39
Current Ratio3.93
Interest Coverage-11.07
Valoración
P/E Ratio
-6.71
P/B Ratio117.60
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 550.00% | Revenue Growth (3Y) | -15.02% |
| Earnings Growth (1Y) | -108.30% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -34.64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.30M | Net Income (TTM) | -140.06M |
| ROE | -197.85% | ROA | -95.62% |
| Gross Margin | -91.00% | Operating Margin | -10386.54% |
| Net Margin | -10773.46% | Free Cash Flow (TTM) | -129.83M |
| ROIC | -88.06% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 13.39 | Current Ratio | 3.93 |
| Interest Coverage | -11.07 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.71 | P/B Ratio | 117.60 |
| P/S Ratio | 723.05 | PEG Ratio | 0.08 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 939.96M | Enterprise Value | 922.75M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.30M | 200,000.0 | 1.80M | 2.19M | 7.13M |
| Net Income | -140.06M | 1.69B | -241.36M | -145.23M | -81.77M |
| EPS (Diluted) | -9.04 | 116.58 | -5.12 | -3.62 | -2.15 |
| Gross Profit | -1.18M | -2.09M | 609,000.0 | -107.99M | 4.44M |
| Operating Income | -135.03M | -331.45M | -219.22M | -129.12M | -76.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 146.48M | 180.77M | 307.89M | 290.88M | 150.45M |
| Total Liabilities | 138.49M | 47.18M | 264.39M | 232.82M | 98.07M |
| Shareholders' Equity | 7.99M | 133.58M | 43.50M | 58.06M | 52.38M |
| Total Debt | 107.01M | 8.05M | 210.14M | 207.10M | 72.14M |
| Cash & Equivalents | 124.22M | 152.60M | 277.92M | 273.87M | 131.30M |
| Current Assets | 132.83M | 160.40M | 295.36M | 280.49M | 139.11M |
| Current Liabilities | 33.80M | 40.73M | 56.31M | 27.58M | 22.45M |